Margrit Carlson

The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults

J Michael Kilby, Jacob Lalezari, Joseph J. Eron et al. · AIDS Research and Human Retroviruses · 2002 · 197 citations

A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy

Jacob Lalezari, Joseph J. Eron, Margrit Carlson et al. · AIDS · 2003 · 148 citations

Characteristics of Untreated AIDS-related Cytomegalovirus Retinitis. II. Findings in the Era of Highly Active Antiretroviral Therapy (1997 to 2000)

Gary N. Holland, Jean D. Vaudaux, Kevin M. Shiramizu et al. · American Journal of Ophthalmology · 2008 · 94 citations

Viral Persistence, Human Retrovirus, Immunology +6

A Controlled Phase Ii Trial Assessing Three Doses of Enfuvirtide (T-20) in Combination with Abacavir, Amprenavir, Ritonavir and Efavirenz in Non-Nucleoside Reverse Transcriptase Inhibitor-Naive HIV-Infected Adults

Jacob Lalezari, Edwin DeJesus, Donald W. Northfelt et al. · Antiviral Therapy · 2003 · 79 citations · Full text

Most Isrs, Antiviral Compound, Health Sciences +13

Hepatitis E Virus–Associated Meningoencephalitis in a Lung Transplant Recipient Diagnosed by Clinical Metagenomic Sequencing

Jamie A. Murkey, Kara W Chew, Margrit Carlson et al. · Open Forum Infectious Diseases · 2017 · 76 citations · Full text

Lung Transplantation, Diagnostic Virology, Clinical Metagenomic Sequencing +13